EPISTAXIS AND ALLERGIC RHINITIS IN ATHLETES: PREVALENCE ACROSS SPORTS AND CONTEMPORARY MANAGEMENT STRATEGIES BASED ON LATEST EVIDENCE – A NARRATIVE REVIEW
Abstract
Purpose: This study aims to evaluate the prevalence of epistaxis and allergic rhinitis among athletes across different sports disciplines, and to review current management strategies based on recent clinical evidence.
Materials and Methods: A comprehensive literature review was conducted, analyzing epidemiological data on epistaxis and allergic rhinitis incidence in various sports including contact, endurance, and outdoor disciplines. Management protocols were assessed with a focus on conservative, pharmacologic, and interventional treatments reported in randomized controlled trials and clinical guidelines.
Results: Epistaxis was found to be more prevalent in contact sports such as boxing and rugby, predominantly due to trauma, whereas endurance and outdoor sports athletes experienced nosebleeds related to environmental dryness and mucosal irritation. Allergic rhinitis prevalence correlated strongly with exposure to allergens, particularly in outdoor sports during pollen seasons. Conservative management, including nasal compression and topical treatments, was effective in most anterior epistaxis cases. Cauterization and nasal packing remained standard for refractory bleeds, with newer hemostatic agents and tranexamic acid showing promising results. Allergic rhinitis was best managed through allergen avoidance, nasal saline irrigation, and intranasal corticosteroids, with combination antihistamine-corticosteroid sprays providing superior symptom control.
Conclusions: Epistaxis and allergic rhinitis represent significant yet manageable health concerns in athletes, with prevalence influenced by sport type and environmental factors. Tailored, sport-specific management strategies improve outcomes and reduce performance disruptions. Further research into preventative measures and individualized therapies is warranted to enhance athlete care.
References
Kucik CJ, Clenney T. Management of epistaxis. Am Fam Physician. 2005 Jan 15;71(2):305-11. PMID: 15686301.
Tunkel DE, Anne S, Payne SC, et al. Clinical Practice Guideline: Nosebleed (Epistaxis) Executive Summary. Otolaryngol Head Neck Surg. 2020;162(1):8–25. doi: 10.1177/0194599819889955
Schlosser RJ. Clinical practice. Epistaxis. N Engl J Med. 2009;360(8):784–789. doi: 10.1056/NEJMcp0807078
Riviello RJ, Brown N. Otolaryngologic procedures. In: Roberts JR, Hedges JR (Eds). Clinical Procedures in Emergency Medicine, 4th ed. WB Saunders, Philadelphia. 2004:1300.
Gudis DA, Soler ZM. Nasal Cauterization with Silver Nitrate for Recurrent Epistaxis. N Engl J Med. 2021;384:e101. doi: 10.1056/NEJMvcm2020073
Toner JG, Walby AP. Comparison of electro and chemical cautery in the treatment of anterior epistaxis. J Laryngol Otol. 1990;104:617. doi: 10.1017/s0022215100113398
Mudunuri RKR, Murthy MA. The Treatment of Spontaneous Epistaxis: Conservative vs Cautery. J Clin Diagn Res. 2012;6(9):1523–1524. doi: 10.7860/JCDR/2012/4215.2548
Corbridge RJ, Djazaeri B, Hellier WP, Hadley J. A prospective randomized controlled trial comparing the use of Merocel nasal tampons and BIPP in the control of acute epistaxis. Clin Otolaryngol Allied Sci. 1995;20(4):305–307. doi: 10.1111/j.1365-2273.1995.tb00047.x
Badran K, Malik TH, Belloso A, Timms MS. Randomized controlled trial comparing Merocel and RapidRhino packing in the management of anterior epistaxis. Clin Otolaryngol. 2005;30:333–337. doi: 10.1111/j.1365-2273.2005.01019.x
Singer AJ, Blanda M, Cronin K, et al. Comparison of nasal tampons for the treatment of epistaxis in the emergency department: a randomized controlled trial. Ann Emerg Med. 2005;45:134–139. doi: 10.1016/j.annemergmed.2004.10.002
Akkan S, Çorbacıoğlu ŞK, Aytar H, et al. Evaluating Effectiveness of Nasal Compression With Tranexamic Acid Compared With Simple Nasal Compression and Merocel Packing: A Randomized Controlled Trial. Ann Emerg Med. 2019;74:72–79. doi: 10.1016/j.annemergmed.2019.03.030
Janapala RN, Tran QK, Patel J, et al. Efficacy of topical tranexamic acid in epistaxis: A systematic review and meta-analysis. Am J Emerg Med. 2022;51:169–175. doi: 10.1016/j.ajem.2021.10.043
Reuben A, Appelboam A, Stevens KN, et al. The Use of Tranexamic Acid to Reduce the Need for Nasal Packing in Epistaxis (NoPAC): Randomized Controlled Trial. Ann Emerg Med. 2021;77:631–639. doi: 10.1016/j.annemergmed.2020.12.013
Biswas D, Mal RK. Are systemic prophylactic antibiotics indicated with anterior nasal packing for spontaneous epistaxis? Acta Otolaryngol. 2009;129:179–183. DOI: 10.1080/00016480802043964
Tran QK, Rehan MA, Haase DJ, et al. Prophylactic antibiotics for anterior nasal packing in emergency department: A systematic review and meta-analysis of clinically-significant infections. Am J Emerg Med. 2020;38:983–990. DOI: 10.1016/j.ajem.2019.11.037
Pepper C, Lo S, Toma A. Prospective study of the risk of not using prophylactic antibiotics in nasal packing for epistaxis. J Laryngol Otol. 2012;126:257–262. DOI: 10.1017/S0022215111003215
McGlashan JA, Walsh R, Dauod A, et al. A comparative study of calcium sodium alginate (Kaltostat) and bismuth tribromophenate (Xeroform) packing in the management of epistaxis. J Laryngol Otol. 1992;106:1067–1070. DOI: 10.1017/s0022215100121772
Mathiasen RA, Cruz RM. Prospective, randomized, controlled clinical trial of a novel matrix hemostatic sealant in patients with acute anterior epistaxis. Laryngoscope. 2005;115:899–902. DOI: 10.1097/01.MLG.0000160528.50017.3C
Côté D, Barber B, Diamond C, Wright E. FloSeal hemostatic matrix in persistent epistaxis: prospective clinical trial. J Otolaryngol Head Neck Surg. 2010 Jun;39(3):304-8. PMID: 20470677.
Vaiman M, Segal S, Eviatar E. Fibrin glue treatment for epistaxis. Rhinology. 2002 Jun;40(2):88-91. PMID: 12092000.
Dykewicz, M. S., Kaiser, H. B., Nathan, R. A., et al. (2003). Fluticasone propionate aqueous nasal spray improves nasal symptoms of seasonal allergic rhinitis when used as needed (prn). Annals of Allergy, Asthma & Immunology, 91, 44. https://doi.org/10.1016/S1081-1206(10)62057-1
Patel, P., Patel, D., Kunjibettu, S., et al. (2008). Onset of action of ciclesonide once daily in the treatment of seasonal allergic rhinitis. Ear, Nose & Throat Journal, 87, 340. https://doi.org/10.1177/014556130808700612
Patel, D., Garadi, R., Brubaker, M., et al. (2007). Onset and duration of action of nasal sprays in seasonal allergic rhinitis patients: olopatadine hydrochloride versus mometasone furoate monohydrate. Allergy & Asthma Proceedings, 28, 592. https://doi.org/10.2500/aap2007.28.3033
Couroux, P., Kunjibettu, S., Hall, N., & Wingertzahn, M. A. (2009). Onset of action of ciclesonide once daily in the treatment of seasonal allergic rhinitis. Annals of Allergy, Asthma & Immunology, 102, 62. https://doi.org/10.1016/S1081-1206(10)60110-X
Juel-Berg, N., Darling, P., Bolvig, J., et al. (2017). Intranasal corticosteroids compared with oral antihistamines in allergic rhinitis: A systematic review and meta-analysis. American Journal of Rhinology & Allergy, 31, 19. https://doi.org/10.2500/ajra.2017.31.4411
Zhang, K., Li, A. R., Miglani, A., et al. (2022). Effect of medical therapy in allergic rhinitis: A systematic review and meta-analysis. American Journal of Rhinology & Allergy, 36, 269. https://doi.org/10.1177/19458924211041438
Pullerits, T., Praks, L., Ristioja, V., & Lötvall, J. (2002). Comparison of a nasal glucocorticoid, antileukotriene, and a combination of antileukotriene and antihistamine in the treatment of seasonal allergic rhinitis. Journal of Allergy and Clinical Immunology, 109, 949. https://doi.org/10.1067/mai.2002.124467
Yáñez, A., & Rodrigo, G. J. (2002). Intranasal corticosteroids versus topical H1 receptor antagonists for the treatment of allergic rhinitis: A systematic review with meta-analysis. Annals of Allergy, Asthma & Immunology, 89, 479. https://doi.org/10.1016/S1081-1206(10)62085-6
Juniper, E. F., Ståhl, E., Doty, R. L., et al. (2005). Clinical outcomes and adverse effect monitoring in allergic rhinitis. Journal of Allergy and Clinical Immunology, 115(Suppl), S390. https://doi.org/10.1016/j.jaci.2004.12.014
Zitt, M., Kosoglou, T., & Hubbell, J. (2007). Mometasone furoate nasal spray: A review of safety and systemic effects. Drug Safety, 30, 317. https://doi.org/10.2165/00002018-200730040-00004
Daley-Yates, P. T., Price, A. C., Sisson, J. R., et al. (2001). Beclomethasone dipropionate: Absolute bioavailability, pharmacokinetics and metabolism following intravenous, oral, intranasal and inhaled administration in man. British Journal of Clinical Pharmacology, 51, 400. https://doi.org/10.1046/j.0306-5251.2001.01374.x
Derendorf, H., & Meltzer, E. O. (2008). Molecular and clinical pharmacology of intranasal corticosteroids: Clinical and therapeutic implications. Allergy, 63, 1292. https://doi.org/10.1111/j.1398-9995.2008.01750.x
Berger, W. E., Kaiser, H., Gawchik, S. M., et al. (2003). Triamcinolone acetonide aqueous nasal spray and fluticasone propionate are equally effective for relief of nasal symptoms in patients with seasonal allergic rhinitis. Otolaryngology–Head and Neck Surgery, 129, 16. https://doi.org/10.1016/S0194-5998(03)00526-6
Mandl, M., Nolop, K., & Lutsky, B. N. (1997). Comparison of once daily mometasone furoate (Nasonex) and fluticasone propionate aqueous nasal sprays for the treatment of perennial rhinitis. Annals of Allergy, Asthma & Immunology, 79, 237. https://doi.org/10.1016/S1081-1206(10)63030-X
Berger, W. E., & Meltzer, E. O. (2015). Intranasal spray medications for maintenance therapy of allergic rhinitis. American Journal of Rhinology & Allergy, 29, 273. https://doi.org/10.2500/ajra.2015.29.4215
Carr, W., Bernstein, J., Lieberman, P., et al. (2012). A novel intranasal therapy of azelastine with fluticasone for the treatment of allergic rhinitis. Journal of Allergy and Clinical Immunology, 129, 1282. https://doi.org/10.1016/j.jaci.2012.01.077
Ratner, P. H., Hampel, F., Van Bavel, J., et al. (2008). Combination therapy with azelastine hydrochloride nasal spray and fluticasone propionate nasal spray in the treatment of patients with seasonal allergic rhinitis. Annals of Allergy, Asthma & Immunology, 100, 74. https://doi.org/10.1016/S1081-1206(10)60408-5
Gupta, R., & Fonacier, L. S. (2016). Adverse effects of nonsystemic steroids (inhaled, intranasal, and cutaneous): A review of the literature and suggested monitoring tool. Current Allergy and Asthma Reports, 16, 44. https://doi.org/10.1007/s11882-016-0620-y
Schenkel, E. J., Skoner, D. P., Bronsky, E. A., et al. (2000). Absence of growth retardation in children with perennial allergic rhinitis after one year of treatment with mometasone furoate aqueous nasal spray. Pediatrics, 105, E22. https://doi.org/10.1542/peds.105.2.e22
Allen, D. B., Meltzer, E. O., Lemanske, R. F., Jr., et al. (2002). No growth suppression in children treated with the maximum recommended dose of fluticasone propionate aqueous nasal spray for one year. Allergy and Asthma Proceedings, 23, 407.
Kiningham, R., & Monseau, A. (2015). Caring for wrestlers. Current Sports Medicine Reports, 14(5), 404–412. https://doi.org/10.1249/jsr.0000000000000193
Tuominen, R. (1995). Injuries in national karate competitions in Finland. Scandinavian Journal of Medicine & Science in Sports, 5(1), 44–48. https://doi.org/10.1111/j.1600-0838.1995.tb00010.x
Pieter, W. (2002). Injuries in young taekwondo athletes. Medicine & Science in Sports & Exercise, 34(5), 66.
Pieter, W. (1998). Competition injuries in young karate athletes. British Journal of Sports Medicine, 32, 88.
Pieter, W., Bercades, L., & Heijmans, J. (1998). Injuries in young and adult taekwondo athletes. Kinesiology, 30(1), 22–30.
Tsaklis, P., Beis, K., Abatzides, G., & Pieter, W. (2001). Taekwondo competition injuries in Greek young and adult athletes. European Journal of Sports Traumatology and Related Research, 23, 130–136.
Pieter, W., & Zemper, E. D. (1997). Injury rates in children participating in taekwondo competition. Journal of Trauma, 43(1), 89–95. https://doi.org/10.1097/00005373-199707000-00020
Mostoufi, B., & Sands, J. M. (2022). Sports-related facial trauma. In Clinical Guide to Musculoskeletal Medicine (pp. 3–9). Springer. https://doi.org/10.1007/978-3-030-92042-5
Higuera, S., Lee, E. I., Cole, P., Hollier, L. H., Jr., & Stal, S. (2007). Nasal trauma and the deviated nose. Plastic and Reconstructive Surgery, 120(7), 64S–75S. https://doi.org/10.1097/01.prs.0000260722.91183.50
Rice, D. H. (2003). Cerebrospinal fluid rhinorrhea: Diagnosis and treatment. Current Opinion in Otolaryngology & Head and Neck Surgery, 11(1), 19–22. https://doi.org/10.1097/00020840-200302000-00004
Reehal, P. (2010). Facial injury in sport. Current Sports Medicine Reports, 9(1), 27–34. https://doi.org/10.1249/jsr.0b013e3181cd2c04
Rohrich, R. J., & Adams, W. P., Jr. (2000). Nasal fracture management: Minimizing secondary nasal deformities. Plastic and Reconstructive Surgery, 106(2), 266–273. https://doi.org/10.1097/00006534-200008000-00003
Rubin, A. (2003). Sports injuries and emergencies: A quick-response manual.
Davidson, T. M., & Davidson, D. (1996). Immediate management of epistaxis: Bloody nuisance or ominous sign? The Physician and Sportsmedicine, 24(8), 74–83. https://doi.org/10.3810/psm.1996.08.1381
Lachkar, A., Aabach, A., Elayoubi, F., & Ghailan, R. (2016). Frontal sinus barotrauma: About a case and review of the literature. Pan African Medical Journal, 24, 272. https://doi.org/10.11604/pamj.2016.24.272.5742
Bianco, M., Sanna, N., Bucari, S., et al. (2011). Female boxing in Italy: 2002–2007 report. British Journal of Sports Medicine, 45(7), 563–570. https://doi.org/10.1136/bjsm.2009.061135
Čierna, D., Barrientos, M., Agrasar, C., & Arriaza, R. (2018). Epidemiology of injuries in juniors participating in top-level karate competition. British Journal of Sports Medicine, 52(11), 730–734. https://doi.org/10.1136/bjsports-2017-097756
Hallaçeli, H., Davut, S., Özbek, A., & Aydın, E. (2025). Epidemiological analysis of athlete injuries in Muay Thai in-ring matches. Injury Epidemiology, 12(1), 28. https://doi.org/10.1186/s40621-025-00569-x
Rhinitis A. (2008). 2008 update (in collaboration with the WHO, GA²LEN and AllerGen). Allergy, 63(86), 8. https://doi.org/10.1111/j.1398-9995.2007.01620.x
Bousquet, J., Van Cauwenberge, P., & Khaltaev, N. (2001). Allergic rhinitis and its impact on asthma. Journal of Allergy and Clinical Immunology, 108(5), S147–S334. https://doi.org/10.1067/mai.2001.118891
Helenius, I., & Haahtela, T. (2000). Allergy and asthma in elite summer sport athletes. Journal of Allergy and Clinical Immunology, 106(3), 444–452. https://doi.org/10.1067/mai.2000.107749
Katelaris, C. H., Carrozzi, F. M., & Burke, T. V. (2003). Allergic rhinoconjunctivitis in elite athletes. Sports Medicine, 33, 401–406. https://doi.org/10.2165/00007256-200333060-00002
Lumme, A., Haahtela, T., Öunap, J., et al. (2003). Airway inflammation, bronchial hyperresponsiveness and asthma in elite ice hockey players. European Respiratory Journal, 22(1), 113–117. https://doi.org/10.1183/09031936.03.00112403
Walker, S., Khan-Wasti, S., Fletcher, M., et al. (2007). Seasonal allergic rhinitis and examination performance. Journal of Allergy and Clinical Immunology, 120(2), 381–387. https://doi.org/10.1016/j.jaci.2007.03.034
Blaiss, M. S. (Ed.). (2000). Cognitive, social, and economic costs of allergic rhinitis. Allergy and Asthma Proceedings. https://doi.org/10.2500/108854100778248953
Graham, D. M., & Blais, M. S. (2000). Quality-of-life outcomes of asthma and allergic rhinitis. Pediatric Annals, 29(7), 438–443. https://doi.org/10.3928/0090-4481-20000701-12
Katelaris, C. H., Carrozzi, F. M., Burke, T. V., & Byth, K. (2006). Patterns of allergic reactivity in Olympic athletes. Clinical Journal of Sport Medicine, 16(5), 401–405. https://doi.org/10.1097/01.jsm.0000244606.56935.59
Views:
27
Downloads:
17
Copyright (c) 2025 Jakub Komorowski-Roszkiewicz, Wojciech Ługowski, Julia Samek, Karolina Bartoszewska, Iga Kwiecień, Karol Marcyś, Weronika Matwiejuk, Kamil Dziekoński
This work is licensed under a Creative Commons Attribution 4.0 International License.
All articles are published in open-access and licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0). Hence, authors retain copyright to the content of the articles.
CC BY 4.0 License allows content to be copied, adapted, displayed, distributed, re-published or otherwise re-used for any purpose including for adaptation and commercial use provided the content is attributed.
